Do we still need single-sex clinical trials in cardiology?

[1] Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis [J]. JAMA CARDIOLOGY, 2017, 2 (12) : 1303 - 1313

[2] Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI [10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530]

[3] Drug Policy for an Aging Population - The European Medicines Agency's Geriatric Medicines Strategy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (21) : 1972 - 1974

[4] 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement Results From the First WIN-TAVI Registry [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (01) : 1 - 12

[5] Gender Bias in Studies for Food and Drug Administration Premarket Approval of Cardiovascular Devices [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (02): : 165 - U49

[6] Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details [J]. BMJ OPEN, 2016, 6 (09):

[7] A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study [J]. PLOS ONE, 2017, 12 (08):

[8] Radial Versus Femoral Access for Primary Percutaneous Interventions in ST-Segment Elevation Myocardial Infarction Patients A Meta-Analysis of Randomized Controlled Trials [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (08) : 814 - 823

[9] Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: A systematic review and meta-analysis [J]. AMERICAN HEART JOURNAL, 2018, 195 : 39 - 49

[10] Masoudi FA, 2017, J AM COLL CARDIOL, V69, P1424, DOI 10.1016/j.jacc.2016.12.004

[1] Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation Insights and Results From the PLATINUM Diversity and PROMUS Element Plus Post-Approval Study Pooled Analysis [J]. JAMA CARDIOLOGY, 2017, 2 (12) : 1303 - 1313

[2] Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI [10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530]

[3] Drug Policy for an Aging Population - The European Medicines Agency's Geriatric Medicines Strategy [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (21) : 1972 - 1974

[4] 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement Results From the First WIN-TAVI Registry [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (01) : 1 - 12

[5] Gender Bias in Studies for Food and Drug Administration Premarket Approval of Cardiovascular Devices [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2011, 4 (02): : 165 - U49

[6] Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details [J]. BMJ OPEN, 2016, 6 (09):

[7] A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study [J]. PLOS ONE, 2017, 12 (08):

[8] Radial Versus Femoral Access for Primary Percutaneous Interventions in ST-Segment Elevation Myocardial Infarction Patients A Meta-Analysis of Randomized Controlled Trials [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (08) : 814 - 823

[9] Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: A systematic review and meta-analysis [J]. AMERICAN HEART JOURNAL, 2018, 195 : 39 - 49

[10] Masoudi FA, 2017, J AM COLL CARDIOL, V69, P1424, DOI 10.1016/j.jacc.2016.12.004